Discontinuation of targeted therapy in histiocytic neoplasms with durable responses: the DOTT-HN study. // Blood Advances. – URL: https://www.sciencedirect.com/science/article/pii/S2473952926006737?dgcid=rss_sd_all
Discontinuation of targeted therapy in histiocytic neoplasms with durable responses: the DOTT-HN study. Blood Advances. https://www.sciencedirect.com/science/article/pii/S2473952926006737?dgcid=rss_sd_all
“Discontinuation of targeted therapy in histiocytic neoplasms with durable responses: the DOTT-HN study.” Blood Advances.
@article{article38109,
title = {Discontinuation of targeted therapy in histiocytic neoplasms with durable responses: the DOTT-HN study},
journal = {Blood Advances},
url = {https://www.sciencedirect.com/science/article/pii/S2473952926006737?dgcid=rss_sd_all}
}